Related Experiment Videos
[Experience with timolol in consulting patients (author's transl)]
Klinische Monatsblatter Fur Augenheilkunde
|May 1, 1980
Summary
Timolol effectively lowered intraocular pressure in open-angle glaucoma patients unresponsive to other treatments. This beta-blocker prevented the need for glaucoma surgery in many cases, even with long-term use.
Area of Science:
- Ophthalmology
- Pharmacology
Context:
- Open-angle glaucoma management
- Treatment-resistant intraocular pressure elevation
Purpose:
- Evaluate Timolol efficacy in advanced open-angle glaucoma
- Assess long-term intraocular pressure control with Timolol
Summary:
- Timolol (0.25% and 0.5%) was administered to 78 eyes with open-angle glaucoma previously refractory to other medications.
- Sustained intraocular pressure below 23 mmHg was achieved with Timolol, averting the need for surgical intervention.
- A review of prior long-term glaucoma medications was included.
Impact:
- Timolol provides a viable long-term medical treatment option for refractory open-angle glaucoma.
- Reduces the necessity for glaucoma surgery, improving patient outcomes.
- Demonstrates the sustained efficacy of beta-blockers in managing intraocular pressure.